Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-24-037591
Filing Date
2024-09-20
Accepted
2024-09-20 16:05:48
Documents
16

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 306578
2 ex23-1.htm EX-23.1 3432
  Complete submission text file 0001493152-24-037591.txt   557312

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE imnn-20240912.xsd EX-101.SCH 3254
4 XBRL DEFINITION FILE imnn-20240912_def.xml EX-101.DEF 26564
5 XBRL LABEL FILE imnn-20240912_lab.xml EX-101.LAB 36491
6 XBRL PRESENTATION FILE imnn-20240912_pre.xml EX-101.PRE 25219
19 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 5065
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-281834 | Film No.: 241313414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)